Metropolitan Life Insurance Company (MetLife)’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-14,177
| Closed | -$488K | – | 2608 |
|
|
2020
Q3 | $488K | Hold |
14,177
| – | – | 0.01% | 1231 |
|
|
2020
Q2 | $237K | Hold |
14,177
| – | – | ﹤0.01% | 1692 |
|
|
2020
Q1 | $204K | Sell |
14,177
-192
| -1% | -$2.77K | ﹤0.01% | 1576 |
|
|
2019
Q4 | $481K | Hold |
14,369
| – | – | 0.01% | 1350 |
|
|
2019
Q3 | $301K | Hold |
14,369
| – | – | 0.01% | 1609 |
|
|
2019
Q2 | $299K | Hold |
14,369
| – | – | 0.01% | 1622 |
|
|
2019
Q1 | $321K | Hold |
14,369
| – | – | 0.01% | 1586 |
|
|
2018
Q4 | $344K | Hold |
14,369
| – | – | 0.01% | 1464 |
|
|
2018
Q3 | $392K | Hold |
14,369
| – | – | 0.01% | 1536 |
|
|
2018
Q2 | $386K | Buy |
14,369
+2,501
| +21% | +$67.3K | 0.01% | 1497 |
|
|
2018
Q1 | $378K | Buy |
11,868
+241
| +2% | +$7.67K | 0.01% | 1463 |
|
|
2017
Q4 | $440K | Sell |
11,627
-13,146
| -53% | -$497K | 0.01% | 1373 |
|
|
2017
Q3 | $614K | Hold |
24,773
| – | – | ﹤0.01% | 1551 |
|
|
2017
Q2 | $509K | Buy |
24,773
+5,372
| +28% | +$110K | ﹤0.01% | 1677 |
|
|
2017
Q1 | $422K | Sell |
19,401
-1,395
| -7% | -$30.3K | ﹤0.01% | 1764 |
|
|
2016
Q4 | $425K | Hold |
20,796
| – | – | ﹤0.01% | 1853 |
|
|
2016
Q3 | $312K | Hold |
20,796
| – | – | ﹤0.01% | 2039 |
|
|
2016
Q2 | $225K | Buy |
20,796
+11,179
| +116% | +$121K | ﹤0.01% | 2244 |
|
|
2016
Q1 | $130K | Buy |
9,617
+797
| +9% | +$10.8K | ﹤0.01% | 2392 |
|
|
2015
Q4 | $163K | Buy |
+8,820
| New | +$163K | ﹤0.01% | 2388 |
|